It is not only expressed in a high proportion of ER-positive or HER2-positive BCs, but also in TNBCs of different types, including metaplastic carcinomas, whereas its expression in other cancer types was absent or negligible [26, 27]. The gene discussed is ERBB2; the disease is cancer.